Breaking News, Collaborations & Alliances

IntelGenx, Aquestive Enter ED Collaboration

Will co-develop and commercialize Tadalafil oral films for erectile dysfunction

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Oral drug delivery company, IntelGenx, has entered into a definitive worldwide agreement with Aquestive Therapeutics for the co-development and commercialization of Tadalafil oral films for the treatment of erectile dysfunction (ED).   IntelGenx and Aquestive will each grant to the other exclusive worldwide licenses to their respective intellectual property relating to tadalafil oral film formulation and manufacturing. The companies will jointly undertake further co-development and commercializa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters